According to recent filings covering the 90 days ending February 19, 2026, the three most significant insider holders at Olema Pharmaceuticals are TenPercentOwner Capital Life Sciences Investors, Llc Bain (4.30Mn shares), Director Cyrus Harmon (844.80K shares), TenPercentOwner Biocapital Advisors Lp Paradigm (783.12K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Capital Life Sciences Investors, Llc Bain | 4,300,000 | 13 Jan, 2025 | |
| Cyrus Harmon | 844,798 | 21 Jan, 2026 | |
| Biocapital Advisors Lp Paradigm | 783,118 | 05 Aug, 2024 | |
| G. Walmsley Graham | 700,761 | 18 Dec, 2024 | |
| David C. Myles | Ch. Discov. & Non Clin Dev Off | 687,607 | 14 Jan, 2026 |
| Partners L P/Il Bvf | 447,526 | 14 Jan, 2025 | |
| Andrew Rappaport | 385,965 | 25 Nov, 2025 | |
| Sean Bohen | President And Ceo | 237,650 | 30 Dec, 2025 |
| Shane William Charles Kovacs | Ch. Operating & Financial Off. | 139,727 | 15 Jan, 2026 |
| Sasha Lu Austin | Vp Of Finance And Controller | 16,188 | 17 Feb, 2026 |
| Naseem Zojwalla | Chief Medical Officer | 4,488 | 23 Dec, 2025 |
| Kinney Horn | Chief Business Officer | 2,458 | 14 Mar, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Feb, 2026 | Sasha Lu Austin | Common Stock | A | 11,700 | $0.00 | 16,188 | D | A |
| 20 Jan, 2026 | Cyrus Harmon | Common Stock | D | 10,000 | $26.88 | 727,770 | D | S |
| 15 Jan, 2026 | Shane William Charles Kovacs | Common Stock | D | 100,000 | $28.73 | 139,727 | D | S |
| 14 Jan, 2026 | David C. Myles | Common Stock | D | 35,003 | $28.99 | 542,761 | D | S |
| 14 Jan, 2026 | David C. Myles | Common Stock | A | 50,000 | $4.87 | 592,761 | D | M |
| 14 Jan, 2026 | David C. Myles | Common Stock | D | 14,997 | $28.60 | 577,764 | D | S |
| 14 Jan, 2026 | Cyrus Harmon | Common Stock | D | 3,489 | $29.12 | 737,770 | D | S |
| 13 Jan, 2026 | Shane William Charles Kovacs | Common Stock | D | 3,822 | $28.01 | 239,727 | D | S |
| 13 Jan, 2026 | David C. Myles | Common Stock | D | 49,800 | $27.60 | 542,961 | D | S |
| 13 Jan, 2026 | David C. Myles | Common Stock | D | 200 | $28.49 | 542,761 | D | S |
| 13 Jan, 2026 | David C. Myles | Common Stock | A | 50,000 | $4.87 | 592,761 | D | M |
| 12 Jan, 2026 | David C. Myles | Common Stock | D | 10,000 | $28.34 | 144,846 | I | S |
| 26 Dec, 2025 | Sean Bohen | Common Stock | D | 8,500 | $0.00 | 237,650 | D | G |
| 26 Dec, 2025 | Sean Bohen | - | - | 237,650 | D | |||
| 23 Dec, 2025 | Naseem Zojwalla | - | - | 103,997 | D | |||
| 23 Dec, 2025 | Naseem Zojwalla | - | - | 4,488 | D | |||
| 23 Dec, 2025 | Naseem Zojwalla | Common Stock | A | 50,000 | $7.02 | 103,997 | D | M |
| 23 Dec, 2025 | Naseem Zojwalla | Common Stock | D | 99,509 | $27.66 | 4,488 | D | S |
| 22 Dec, 2025 | Cyrus Harmon | Common Stock | D | 2,881 | $28.53 | 741,259 | D | S |
| 22 Dec, 2025 | Naseem Zojwalla | Common Stock | A | 42,818 | $15.25 | 146,815 | D | M |